James L. Heppell

Insider Reports History

Signature
/s/ James L. Heppell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James L. Heppell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. Director Director Stock Option (Right to Buy) 1,350,000 14 Sep 2021 Direct

Insider Reports Filed by James L. Heppell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SKYE Skye Bioscience, Inc. 14 Sep 2021 1 $0 4 Director 16 Sep 2021, 16:02